Responding to medetomidine: clinical and public health needs

被引：0
作者：
Zhu, David T. [1 ]
Pajamar, Joseph J. [2 ]
机构：
[1] Virginia Commonwealth Univ, Sch Med, Med Scientist Training Program, 1201 E Marshall St, Richmond, VA 23298 USA
[2] NYU, Grossman Sch Med, Dept Populat Hlth, New York, NY USA
来源：
LANCET REGIONAL HEALTH-AMERICAS | 2025年 / 44卷
关键词：
D O I：
10.1016/j.lana.2025.101053
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Baker NJ, 2011, J AM ASSOC LAB ANIM, V50, P916
  • [2] BTNX Inc, 2024, Medetomidine test strip (Liquid/Powder) product insert
  • [3] Letter to the editor: Is medetomidine the next perioperative substance of abuse?
    Haruna, Aminat
    Anyama, Boris
    Chauhan, Gaurav
    Lynch, Brendan
    Viscusi, Eugene R.
    Emerick, Trent
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2025,
  • [4] National Drug Early Warning System (NDEWS), 2024, Alert from the NDEWS web monitoring team: online mentions of Medetomidine
  • [5] New York State Department of Health, 2023, Xylazine awareness in New York state
  • [6] Medetomidine Infiltrates the US Illicit Opioid Market
    Palamar, Joseph J.
    Krotulski, Alex J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (17): : 1425 - 1426
  • [7] Philadelphia Department of Public Health, 2024, Medetomidine detected in Philadelphia's illicit drug supply-clinical implications and public health recommendations
  • [8] The Center for Forensic Science Research & Education, 2024, Medetomidine rapidly proliferating across USA-implicated in recreational opioid drug supply & causing overdose outbreaks
  • [9] Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review
    Zhu, David T.
    [J]. HARM REDUCTION JOURNAL, 2023, 20 (01)
1